Nephrol Dial Transplant (2000) 15: 1624-1630
© 2000 European Renal Association-European Dialysis and Transplant Association
Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease
1 Divisions of Renal Medicine, and 2 Baxter Novum, Department of Clinical Science, and 3 Department of Rheumatology Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Background. Atherosclerotic cardiovascular disease, malnutrition, and increased levels of pro-inflammatory cytokines are common features in patients with chronic renal failure, and contribute to the high mortality rate observed in these patients. A diverse group of soluble cellular adhesion molecules (CAM) (sVCAM-1, sICAM-1 and sE-selectin) are expressed on the surface of vascular endothelial cells in response to pro-inflammatory cytokines and may play an important role in the atherogenic process.
Methods. Serum levels of sVCAM-1, sICAM-1 (n=87) and sE-selectin (n=71) were analysed in a cohort of 88 patients (50±1 years) with chronic renal failure. The presence of malnutrition (subjective global assessment (SGA) and serum albumin), inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-
), and serum hyaluronan), and cardiovascular disease (CVD) were assessed at a time-point close to the start of dialysis treatment (GFR 7±1 ml/min). Blood lipid parameters were also assessed.
Results. Significant correlations were observed between Log high-sensitivity CRP (hsCRP) and sVCAM-1 (R=0.39; P<0.01) and sICAM-1 (R=0.47; P<0.001) levels but not between Log hsCRP and sE-selectin levels in 60 patients examined with a hsCRP assay. Also serum concentrations of Log hyaluronan correlated significantly to sVCAM-1 (R=0.34; P<0.01) and sICAM-1 (R=0.29; P<0.05) levels. Malnourished patients (SGA>1) had elevated serum concentrations of sVCAM-1 (1436±94 vs 1105± 53 ng/ml; P<0.01) compared to well-nourished patients (SGA 1). Patients with clinical signs of CVD (n=26) had elevated serum levels of sICAM-1 (282±18 vs 242±9 ng/ml; P<0.05) compared to 61 patients without signs of CVD. Plasma Log lipoprotein (a) (Lp(a)) levels correlated significantly with sVCAM-1 (R=0.30; P<0.01). Survival analysis by the Cox regression model showed that elevated sICAM-1 was, independent of age, SGA, CVD, and Log CRP, significantly related to an increased mortality rate.
Conclusions. Elevated serum concentrations of soluble adhesion molecules are found in pre-dialysis patients who are malnourished, inflamed, and have signs of cardiovascular disease. These data also suggest that sICAM-1 is an independent predictor of mortality in pre-dialysis patients. Further studies are needed to determine if inflammation causes accelerated atherogenesis via effects on soluble adhesion molecules or if elevated serum levels of soluble adhesion molecules are merely markers of endothelial activation in patients with chronic renal failure.
Keywords: cardiovascular disease; inflammation; Lp(a); malnutrition; mortality; soluble adhesion molecules
Correspondence and offprint requests to: Peter Stenvinkel MD, Department of Renal Medicine K56, Huddinge University Hospital, S-141 86 Huddinge, Sweden.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Q. Guo, J. J. Carrero, X. Yu, P. Barany, A. R. Qureshi, M. Eriksson, B. Anderstam, M. Chmielewski, O. Heimburger, P. Stenvinkel, et al. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3468 - 3473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Tolpin, C. D. Collard, V.-V. Lee, M. A. Elayda, and W. Pan Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 873 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. DeLoach, M. M. Joffe, X. Mai, S. Goral, and S. E. Rosas Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1314 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Naumnik, K. Pawlak, and M. Mys'liwiec Unfractionated Heparin but Not Enoxaparin Causes Delayed Plasma PAI-1 Depletion in Hemodialysis Patients: A Prospective Study Clinical and Applied Thrombosis/Hemostasis, February 1, 2009; 15(1): 84 - 91. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Cukor, S. D. Cohen, R. A. Peterson, and P. L. Kimmel Psychosocial Aspects of Chronic Disease: ESRD as a Paradigmatic Illness J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3042 - 3055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tong, J. J. Carrero, A. R. Qureshi, B. Anderstam, O. Heimburger, P. Barany, J. Axelsson, A. Alvestrand, P. Stenvinkel, B. Lindholm, et al. Plasma Pentraxin 3 in Patients with Chronic Kidney Disease: Associations with Renal Function, Protein-Energy Wasting, Cardiovascular Disease, and Mortality Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Fortes, P. H. Versari, A. E.M. Stinghen, and R. Pecoits-Filho CONTROLLING INFLAMMATION IN PERITONEAL DIALYSIS: THE ROLE OF PD-RELATED FACTORS AS POTENTIAL INTERVENTION TARGETS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S76 - S81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Suliman, A. R. Qureshi, O. Heimburger, B. Lindholm, and P. Stenvinkel Soluble adhesion molecules in end-stage renal disease: a predictor of outcome Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1603 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arici, S. Kahraman, G. Genctoy, B. Altun, U. Kalyoncu, A. Oto, S. Kirazli, Y. Erdem, U. Yasavul, and C. Turgan Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis? Nephrol. Dial. Transplant., April 1, 2006; 21(4): 999 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. C. Grooteman, M. Gritters, I. M. P. M. J. Wauters, C. G. Schalkwijk, F. Stam, J. Twisk, P. M. ter Wee, and M. J. Nube Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2751 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali, G. Tripepi, S. Cutrupi, P. Pizzini, and F. Mallamaci Low Triiodothyronine: A New Facet of Inflammation in End-Stage Renal Disease J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2789 - 2795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tripepi, F. Mallamaci, and C. Zoccali Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S83 - S88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rahman, C. D. Brown, J. Coresh, B. R. Davis, J. H. Eckfeldt, N. Kopyt, A. S. Levey, C. Nwachuku, S. Pressel, E. Reisin, et al. The Prevalence of Reduced Glomerular Filtration Rate in Older Hypertensive Patients and Its Association With Cardiovascular Disease: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Arch Intern Med, May 10, 2004; 164(9): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Kaysen and J. P. Eiserich The Role of Oxidative Stress-Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction J. Am. Soc. Nephrol., March 1, 2004; 15(3): 538 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu, S.-P. Zhao, Y.-C. Cheng, and Y.-L. Li Xuezhikang Decreases Serum Lipoprotein(a) and C-reactive Protein Concentrations in Patients with Coronary Heart Disease Clin. Chem., August 1, 2003; 49(8): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Suliman, O. Heimburger, P. Barany, B. Anderstam, R. Pecoits-Filho, E. Rodriguez Ayala, A. R. Qureshi, I. Fehrman-Ekholm, B. Lindholm, and P. Stenvinkel Plasma Pentosidine Is Associated with Inflammation and Malnutrition in End-Stage Renal Disease Patients Starting on Dialysis Therapy J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1614 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Shlipak, L. F. Fried, C. Crump, A. J. Bleyer, T. A. Manolio, R. P. Tracy, C. D. Furberg, and B. M. Psaty Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency Circulation, January 7, 2003; 107(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Papagianni, M. Kalovoulos, D. Kirmizis, A. Vainas, A.-M. Belechri, E. Alexopoulos, and D. Memmos Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients Nephrol. Dial. Transplant., January 1, 2003; 18(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Papayianni, E. Alexopoulos, P. Giamalis, L. Gionanlis, A.-M. Belechri, P. Koukoudis, and D. Memmos Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events Nephrol. Dial. Transplant., March 1, 2002; 17(3): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Borawski and M. Mysiwiec Effects of Recombinant Erythropoietin Therapy on Circulating Endothelial Markers in Hemodialysis Patients Clinical and Applied Thrombosis/Hemostasis, January 1, 2002; 8(1): 77 - 84. [Abstract] [PDF]
|
|
|
|
|
|
R. Gokal Peritoneal Dialysis in the 21st Century: An Analysis of Current Problems and Future Developments J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S104 - 115. [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel Endothelial dysfunction and inflammation--is there a link? Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1968 - 1971. [Full Text] [PDF]
|
|
|
|
|
|
A. Y. M. WANG, J. WOO, M. WANG, M. M. M. SEA, R. IP, P. K. T. LI, S. F. LUI, and J. E. SANDERSON Association of Inflammation and Malnutrition with Cardiac Valve Calcification in Continuous Ambulatory Peritoneal Dialysis Patients J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1927 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Borawski, B. Naumnik, K. Pawlak, and M. Mysliwiec Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1442 - 1447. [Abstract] [Full Text] [PDF]
|
|